NAR - Marker-free Quantification of Repair Pathway Utilization at Cas9-induced Double-Strand Breaks

Published: 31 March 2021| Version 1 | DOI: 10.17632/3nw4bztjns.1
Contributors:
Wanjuan Feng,
Dennis Simpson,
Jang Eun Cho,
Juan Carvajal-Garcia,
Chelsea Smith,
Kathryn Headley,
Nate Hathaway,
Dale Ramsden,
Gaorav Gupta

Description

Genome integrity and genome engineering require efficient repair of DNA double-strand breaks (DSBs) by non-homologous end joining (NHEJ), homologous recombination (HR), or alternative end-joining pathways. Here we describe two complementary methods for marker-free quantification of DSB repair pathway utilization at Cas9-targeted chromosomal DSBs in mammalian cells. The first assay features the analysis of amplicon next-generation sequencing data using ScarMapper, an iterative break-associated alignment algorithm to classify individual repair products based on deletion size, microhomology usage, and insertions. The second assay uses repair pathway-specific droplet digital PCR assays (“PathSig-dPCR”) for absolute quantification of signature DSB repair outcomes. We show that ScarMapper and PathSig-dPCR enable comprehensive assessment of repair pathway utilization in different cell models, after a variety of experimental perturbations. We use these assays to measure the differential impact of DNA end resection on NHEJ, HR, and polymerase theta-mediated end joining (TMEJ) repair. These approaches are adaptable to any cellular model system and genomic locus where Cas9-mediated targeting is feasible. Thus, ScarMapper and PathSig-dPCR allow for systematic fate mapping of a targeted DSB with facile and accurate quantification of DSB repair pathway choice at endogenous chromosomal loci.

Files

Institutions

University of North Carolina at Chapel Hill

Categories

DNA Repair, Next Generation Sequencing

License